ES2079872T3 - Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina. - Google Patents

Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.

Info

Publication number
ES2079872T3
ES2079872T3 ES92913037T ES92913037T ES2079872T3 ES 2079872 T3 ES2079872 T3 ES 2079872T3 ES 92913037 T ES92913037 T ES 92913037T ES 92913037 T ES92913037 T ES 92913037T ES 2079872 T3 ES2079872 T3 ES 2079872T3
Authority
ES
Spain
Prior art keywords
descarboxil
aciltioalquilprostaglandina
derivatives
hypotensive
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92913037T
Other languages
English (en)
Inventor
Ming Fai Chan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ES2079872T3 publication Critical patent/ES2079872T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A PROSTAGLANDINAS DE 2DECARBOXIL-2-ACILTIOALQUILO QUE SON HIPOTENSOS OCULARES POTENTES, Y SON PARTICULARES CONVENIENTES PARA EL MANEJO DE GLAUCOMA.
ES92913037T 1991-05-17 1992-05-13 Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina. Expired - Lifetime ES2079872T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/702,220 US5312832A (en) 1991-05-17 1991-05-17 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives

Publications (1)

Publication Number Publication Date
ES2079872T3 true ES2079872T3 (es) 1996-01-16

Family

ID=24820309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92913037T Expired - Lifetime ES2079872T3 (es) 1991-05-17 1992-05-13 Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.

Country Status (10)

Country Link
US (1) US5312832A (es)
EP (1) EP0585380B1 (es)
JP (1) JPH06507897A (es)
AT (1) ATE130603T1 (es)
AU (1) AU653240B2 (es)
CA (1) CA2102295A1 (es)
DE (1) DE69206262T2 (es)
ES (1) ES2079872T3 (es)
HU (1) HUT65913A (es)
WO (1) WO1992020648A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312842A (en) * 1992-10-30 1994-05-17 Allergan, Inc. Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-aliphatic or aryl aliphatic derivatives
US5516796A (en) * 1994-03-24 1996-05-14 Kabi Pharmacia Ab Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
DE60003435T2 (de) 1999-08-04 2004-05-19 The Procter & Gamble Company, Cincinnati Neue 2-decarboxy-2-phosphinico prostaglandin f analoge
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
WO2007093839A1 (en) * 2006-02-16 2007-08-23 Sederma New polypeptides kxk and their use
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
JPS5334747A (en) * 1976-09-14 1978-03-31 Ono Pharmaceut Co Ltd Prostaglandin-like compounds and their preparation
EP0051284B1 (en) * 1980-10-31 1985-01-09 Teijin Limited Novel thiaprostaglandin e1 derivatives, process for production thereof, and pharmaceuticals containing these compounds
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives

Also Published As

Publication number Publication date
AU2006692A (en) 1992-12-30
DE69206262T2 (de) 1996-07-18
DE69206262D1 (de) 1996-01-04
HUT65913A (en) 1994-07-28
AU653240B2 (en) 1994-09-22
US5312832A (en) 1994-05-17
EP0585380B1 (en) 1995-11-22
EP0585380A1 (en) 1994-03-09
CA2102295A1 (en) 1992-11-18
WO1992020648A1 (en) 1992-11-26
ATE130603T1 (de) 1995-12-15
JPH06507897A (ja) 1994-09-08

Similar Documents

Publication Publication Date Title
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
EP1225168A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE158506T1 (de) Okulare hypotensive 2-dekarboxyl-2-aminoalkyl- prostaglandine
SE8703854D0 (sv) Prostaglandinderivat for behandling av glaukom eller okuler hypertension
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
IT1247796B (it) Derivati arilvinilamidici e procedimento per la loro preparazione
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
WO1992010473A3 (en) 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
DE59207900D1 (de) Iloprost mit wirkung gegen cerebrale malaria
WO1992010193A3 (en) Homo-prostaglandin derivatives as ocular hypotensives
ES2060944T3 (es) Derivados de 2,5,6,7-tetranor-4,8-inter-m-fenileno de pgi2 (prostaglandina i2).
NO921317L (no) Antimetastatisk virkende midler
SU875555A1 (ru) Устройство дл синхронного включени нагрузки
BE860603A (fr) Derives de l'oxadiazole-1,2,4 utilisables comme azureurs optiques
ATE138574T1 (de) Verwendung von prostaglandin f3alpha als okulares hypotensivum
ITVR920084A0 (it) Procedimento di produzione di stanghetta per occhiale, nonche' stanghetta realizzata mediante tale procedimento
EP1300150A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
NO923546L (no) Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde
NO923642L (no) Anvendelse av 5-trans-prostaglandin f2alfa som et okulart hypotensivt middel
ES1014943Y (es) Protesis ocular profilactica de la cinetosis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 585380

Country of ref document: ES